Cargando…
A Massive Overdose of Dalfampridine
Multiple sclerosis (MS) is an immune mediated inflammatory disease that attacks myelinated axons in the central nervous system. Dalfampridine (4-aminopyridine) was approved by the Food and Drug Administration in January 2010 for treatment of MS. Our patient was a 34-year-old male with a history of M...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703168/ https://www.ncbi.nlm.nih.gov/pubmed/26759675 http://dx.doi.org/10.5811/westjem.2015.8.26127 |